130 related articles for article (PubMed ID: 9176596)
1. Mivacurium.
Feldman S
Br J Hosp Med; 1997 Mar 5-18; 57(5):199-201. PubMed ID: 9176596
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block.
Beaufort TM; Nigrovic V; Proost JH; Houwertjes MC; Wierda JM
Anesthesiology; 1998 Sep; 89(3):707-14. PubMed ID: 9743409
[TBL] [Abstract][Full Text] [Related]
3. [Prolonged neuromuscular block after mivacurium injection].
Viggiano M; Soler C; Dumont JC; Pellissier D; François G
Ann Fr Anesth Reanim; 1995; 14(6):502-4. PubMed ID: 8745974
[TBL] [Abstract][Full Text] [Related]
4. Mivacurium chloride--a comparative profile.
Diffenbach C; Buzello W; Mellinghoff H
Acta Anaesthesiol Scand Suppl; 1995; 106():23-5. PubMed ID: 8533540
[TBL] [Abstract][Full Text] [Related]
5. Effects of succinylcholine on the recovery of block produced by mivacurium in rats.
Kanyamibwa D; Tsaousi G; Karakoulas K; Thomareis O; Parlapani A; Makedou AH; Giala M
Methods Find Exp Clin Pharmacol; 2008 Apr; 30(3):187-91. PubMed ID: 18597002
[TBL] [Abstract][Full Text] [Related]
6. The clinical and basic pharmacology of mivacurium: a short-acting nondepolarizing benzylisoquinolinium diester neuromuscular blocking drug.
Savarese JJ; Lien CA; Belmont MR; Rubin L
Acta Anaesthesiol Scand Suppl; 1995; 106():18-22. PubMed ID: 8533538
[TBL] [Abstract][Full Text] [Related]
7. Prolonged neuromuscular block associated with mivacurium.
Fox MH; Hunt PC
Br J Anaesth; 1995 Feb; 74(2):237-8. PubMed ID: 7696077
[TBL] [Abstract][Full Text] [Related]
8. Mivacurium in infants and children.
Goudsouzian NG
Paediatr Anaesth; 1997; 7(3):183-90. PubMed ID: 9189962
[TBL] [Abstract][Full Text] [Related]
9. Clinical importance of plasma cholinesterase for the anaesthetist.
Pedersen NA; Jensen FS
Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):120-4. PubMed ID: 7710221
[TBL] [Abstract][Full Text] [Related]
10. Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury.
Martyn JA; Goudsouzian NG; Chang Y; Szyfelbein SK; Schwartz AE; Patel SS
Anesthesiology; 2000 Jan; 92(1):31-7. PubMed ID: 10638896
[TBL] [Abstract][Full Text] [Related]
11. [The clinical pharmacology of mivacurium].
Diefenbach C; Mellinghoff H
Anaesthesist; 1997 May; 46(5):385-8. PubMed ID: 9245207
[TBL] [Abstract][Full Text] [Related]
12. Newer neuromuscular blocking agents.
Bevan DR
Pharmacol Toxicol; 1994 Jan; 74(1):3-9. PubMed ID: 8159634
[TBL] [Abstract][Full Text] [Related]
13. Mivacurium-induced prolonged neuromuscular block.
Sockalingam I; Green DW
Br J Anaesth; 1995 Feb; 74(2):234-6. PubMed ID: 7696076
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of mivacurium in pediatric patients.
Zeng R; Liu X; Zhang J; Yin N; Fei J; Zhong S; Hu Z; Hu M; Zhang M; Li B; Li J; Lian Q; ShangGuan W
BMC Anesthesiol; 2017 Apr; 17(1):58. PubMed ID: 28415988
[TBL] [Abstract][Full Text] [Related]
15. Test dose for prediction of mivacurium sensitivity in the patient with atypical plasma cholinesterase.
Baraka A
Anesthesiology; 1995 Dec; 83(6):1371-2. PubMed ID: 8533937
[No Abstract] [Full Text] [Related]
16. Dose-response relationship for mivacurium in patients with phenotypically abnormal plasma cholinesterase activity.
Ostergaard D; Jensen FS; Skovgaard LT; Viby-Mogensen J
Acta Anaesthesiol Scand; 1995 Nov; 39(8):1016-8. PubMed ID: 8607300
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of mivacurium in severely burned patients.
Werba AE; Neiger FX; Bayer GS; Schultz AM; Maitz PK; Wolrab C
Burns; 1996 Feb; 22(1):62-4. PubMed ID: 8719320
[TBL] [Abstract][Full Text] [Related]
18. Mivacurium block in patients with abnormal plasma cholinesterase.
Viby-Mogensen J
Acta Anaesthesiol Scand; 1995 Nov; 39(8):1001-2. PubMed ID: 8607297
[No Abstract] [Full Text] [Related]
19. Duration of action and hemodynamic properties of mivacurium chloride in dogs anesthetized with halothane.
Smith LJ; Moon PF; Lukasik VM; Erb HN
Am J Vet Res; 1999 Sep; 60(9):1047-50. PubMed ID: 10490069
[TBL] [Abstract][Full Text] [Related]
20. Cholinesterase inhibition by potato glycoalkaloids slows mivacurium metabolism.
McGehee DS; Krasowski MD; Fung DL; Wilson B; Gronert GA; Moss J
Anesthesiology; 2000 Aug; 93(2):510-9. PubMed ID: 10910502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
